International Ibuprofen Foundation

 
What is IbuprofenUses of IbuprofenSuitabilityNews & EventsAbout IIFContact Us
  Girl Reading   Newsletters  
Home > News & Events > Newsletters
 

Newsletters
Media Releases
Conferences
Photo Library
   

 


Ibuprofen reduces cognitive decline in older women

Women who are long-term users of NSAIDs - primarily ibuprofen - are less likely to have low cognitive function and may be at reduced risk of substantial cognitive decline, say US investigators1.

The study aimed to determine the effects of aspirin and other NSAIDs on cognitive function in 13,255 women aged 70 - 81 participating in the Nurses’ Health Study, an ongoing cohort study in the United States. Aspirin was currently used by 59 percent of participants and formerly used by 34 percent; the corresponding figures for NSAIDs were 24 and 29 percent. Most
women said the NSAID they used was ibuprofen.
Psychometric tests were carried out at baseline then repeated two years later; in particular cognitive function was measured by a version of the Mini Mental State Exam adapted for telephone use.

After adjustment for confounding factors such as age, morbidity and education, there was a trend for better performance in tests
of short-term memory and cognitive function with long-term use of aspirin or NSAIDs. Compared with women who had never used aspirin, current use of aspirin lasting 15 or more years was associated with reduced odds of low cognitive function (relative risk 0.79; CI95% 0.59, 0.96); for current NSAID use lasting at
least 8 years, the relative risk was 0.75 (CI95% 0.62, 1.02). The relative risk for substantial global decline in cognitive function (defined as the worst 10 percent of results) was 0.77 (CI95% 0.57, 1.05) for ibuprofen and 0.93 (CI95% 0.68, 1.26) for
aspirin.

The authors say that NSAIDs did not greatly affect cognitive function among older women but long-term use was associated with modestly better scores in psychometric tests and possibly a reduced risk of substantial cognitive decline.

Longer follow-up is needed but they suggest that, if the putative protective effect of NSAIDs against dementia is real, the early phase of the disease is not the most critical for intervention.

1. Hee Kang J, Grodstein F. Regular use of NSAIDs and cognitive function in aging women. Neurology. 2003 May 27;60(10):1591-7.

Contact us
For more information.

 

 

© International Ibuprofen Foundation | Terms & Conditions | Privacy Policy | Designed & Hosted by Alchemy Digital